Diversion and Abuse of Buprenorphine
Diversion and Abuse of Buprenorphine
Diversion and Abuse of Buprenorphine
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
APPENDIX B<br />
INFORMATION SOURCES CONSULTED FOR THE ASSESSMENT<br />
_________________________________________________________________<br />
NATIONAL DATA<br />
Automation <strong>of</strong> Reports <strong>and</strong> Consolidated Orders System (ARCOS)<br />
Drug <strong>Abuse</strong> Warning Network (DAWN) – Emergency Department Data<br />
Drug <strong>Abuse</strong> Warning Network (DAWN) – Medical Examiner <strong>and</strong> Coroner Dataset<br />
National Forensic Laboratory Information System (NFLIS)<br />
DEA Theft <strong>and</strong> Loss Reports (106 Forms)<br />
Manufacturer’s Post-Marketing Surveillance System (as reported at a CSAT conference)<br />
RADARS data (as reported at a CSAT conference)<br />
STATE-LEVEL DATA<br />
New Engl<strong>and</strong> Poison Control Center<br />
Vermont Treatment Program Data<br />
Vermont Medicaid Claims Data<br />
State <strong>and</strong> Local Law Enforcement <strong>and</strong> Laboratory Data<br />
Vermont <strong>Buprenorphine</strong> Guidelines<br />
OTHER INFORMATION<br />
Literature Review<br />
Emailed Key Informant Survey<br />
2003 <strong>Buprenorphine</strong> Summit Consensus Statement<br />
2005 <strong>Buprenorphine</strong> Summit Draft Report<br />
NASADAD Survey <strong>of</strong> State Directors<br />
WHO Scheduling Material<br />
<strong>Buprenorphine</strong> Assessment: Final Report 25